September 1, 2007
By:Jennifer Carter
In light of these recent decisions, patent holders must devise new strategies for patent enforcement and licensing.
 |
June 1, 2007
By:Judy M. Mohr, Gina Freschi
Addition of a disclaimer to a claim, based on words not present in the application as filed, is referred to as an undisclosed disclaimer.
|
March 1, 2007
By:Sergio Garcia
Although IP due diligence is relevant to virtually any transaction between biotech companies, a detailed investigation into IP assets is particularly critical to M&A transactions.
|
January 1, 2007
By:David A. Gay, William Gaede
The Act will establish third party rights to challenge the validity of a patent through postgrant opposition proceedings.
|
| 
